[InvivoscribeBooth]
Catching up on fantastic sessions of #ESHBMFD2020. Yigal Dror discussing the treatment of ribosomopathies. Androgens and G-CSF have been around for a while, BMT outcomes might be better without TBI. Exciting new therapies include ataluren and TGF-B inhibitors. #SDS #DBA
2A nice model of leukemogenesis in Fanconi anemia: Evi1 overexpression in Fanca-/- mice leads to AML with complex karyotypic abnormalities. #ESHBMFD2020 by Susanne Lux.
3Great meeting thanks to all chairs, speakers & attendees. Missed something? Revisit the talks, discussions, posters and satellite symposia on the Conference E-platform in the recorded programme on demand. #ESHBMFD2020
Thank you for these 3 great interactive days!
The E-Conference platform remains open:
Access the on demand programme: https://bit.ly/3eXSIc9
Visit the Exhibition: https://bit.ly/3ks6xRb
#ESHBMFD2020
#ESHCONFERENCES
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.